Means and Methods for Preventing and/or Treating Caries

a caries and microorganism technology, applied in the field of microorganisms, can solve the problems of insufficient stability of prior art agents, ineffective treatment of caries, and inability to provide stable agents

Inactive Publication Date: 2012-09-20
BASF AG
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

On the other hand, the organic acids demineralise dental enamel, leading to cariotic lesions.
However, the role of these proteins in the adhesion of cariogenic bacteria is discussed controversially.
Alternatively, the prior art provides agents which may not be stable enough for a prolonged period in the oral cavity to exert their potential anticariogenic effect.
In addition, the agents of the prior art so far suggested to be useful for treating caries, e.g., enzyme preparations, chemical compounds, etc. may not be cold-stable, pH-stable and / or thermostable which renders them rather ineffective.
Furthermore, some of them bear the risk of adverse side effects.
For example, streptococcal antigens which are suggested to be used for vaccination against caries may cause severe problems associated with vaccination.
To summarize, the prior art does not provide an agent which is not harmful for the subject in need of caries prophylaxis and / or treatment, which can be effectively and easily used for treating caries and which can be cheaply produced in large amounts.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Means and Methods for Preventing and/or Treating Caries
  • Means and Methods for Preventing and/or Treating Caries

Examples

Experimental program
Comparison scheme
Effect test

example 1

Storage and Growth

[0216]Storage and growth of strains can occur according to ordinary procedures. For example, strains can be stored as frozen stocks at −80° C. 1 ml of a culture can be grown to stationary phase (OD600 / mL 4-8) in MRS-Medium and mixed with 500 μl of a sterile 50% glycerine solution and frozen. Cultures of S. mutans can be grown in TSY-media to stationary phase (OD600 / mL 1-2) and treated as mentioned above. Cultivation of S. mutans (DSMZ 20523, serotype c; NCTC 10923, serotype e; NCTC 11060, serotype f as well as non serotyped isolates) as well as cultivation of lactobacilli can be done in 5 ml in closed Falcon tubes at 37° C. without shacking over night.

[0217]In particular, the strains used in the present application were stored as frozen stocks at −80° C. 1 ml of a culture grown to stationary phase (OD600 / mL 4-8) in MRS-broth was mixed with 500 μl of a sterile 50% glycerol solution and frozen.

[0218]In particular, cultures of S. mutans were grown in TSY-broth to stat...

example 2

Taxonomic Classification of Strains

[0220]The taxonomic classification of the strains was done according to their carbohydrate fermentation pattern. This was determined using the API 50 CH (bioMerieux, France) system and analyzed using APILAB PLUS software version 3.3.3 (bioMerieux, France).

example 3

Test on Aggregation of Streptococcus mutans

[0221]Mixing of the lactobacilli with S. mutans was done in volumetric ratios of 3:1 to 60:1 (S. mutans:lactobacilli), this corresponds to a ratio of colony forming units from 1:50 to 1:2.5. An optical density measured at a wavelength of 600 nm in 1 ml means preferably for S. mutans 3×108 colony forming units and for lactobacilli preferably 7×109 colony forming units. Mixing was done in 2 mL volume in 15 mL Falcon tubes. The culture suspensions were diluted with PBS-buffer to obtain the volumetric ratios mentioned above while keeping the final volume at 2 ml. The mixture was vortexed for 15 seconds. An aggregation is visible as an immediate turbidity of the suspension. The tubes were left undisturbed for 20 min, after that period of time the aggregates settle as a visible pellet whereas non-aggregating mixtures stay in suspension.

[0222]As a control, self-aggregation of the respective Lactobacillus strain and the S. mutans strains was alway...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
volumeaaaaaaaaaa
volumeaaaaaaaaaa
temperatureaaaaaaaaaa
Login to view more

Abstract

The present invention relates to a microorganism belonging to the group of lactic acid bacteria capable of specifically binding to Streptococcus mutans, wherein the specific binding is (i) resistant to heat treatment; (ii) resistant to protease treatment; (iii) calcium-dependent; (iv) formed within a pH range between 4.5 and 8.5; and / or (v) formed in the presence of saliva. The present invention is also relates to an analog or fragment of the microorganism which is thermally inactivated or lyophilized, wherein the analog or fragment retains the capability of specifically binding to Streptococcus mutans. The invention further encompasses compositions and additives for food, feed or drinks comprising the microorganism or an analog or fragment thereof. Also provided is uses of the microorganism or an analog or fragment thereof for the preparation of an anticariogenic or pharmaceutical composition or anticariogenic food or feedstuff as well as methods for producing the compositions or food or feedstuff.

Description

RELATED APPLICATIONS[0001]This application is a continuation of U.S. application Ser. No. 11 / 662,347, filed Mar. 8, 2007, which is a national stage application (under 35 U.S.C. §371) of PCT / EP2005 / 009724, filed Sep. 9, 2005, which claims benefit of U.S. Provisional Application 60 / 608,381, filed Sep. 10, 2004, and European application 04021591.5, filed Sep. 10, 2004.FIELD OF THE INVENTION[0002]The present invention relates to a microorganism belonging to the group of lactic acid bacteria characterized in that it is capable of specifically binding to Streptococcus mutans, wherein the specific binding is (i) resistant to heat treatment; and / or (ii) resistant to protease treatment; and / or (iii) calcium-dependent; and / or (iv) formed within a pH range between 4.5 and 8.5; and / or (v) formed in the presence of saliva. Preferably, the specific binding can be assayed as follows:[0003](a) growing said microorganism to stationary phase;[0004](b) mixing said microorganism with Streptococcus muta...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K8/99C12N1/20A61Q11/00A61P19/00A61K35/74A61K9/68A23L13/60A23L15/00A23L17/00A23L27/60A23L29/00A61K35/747
CPCA23G3/366A23G4/123A23L1/3014A23V2002/00A23Y2220/73A61K8/99A61K35/747C12R1/225C12N1/20A61Q11/00A23V2200/312A23V2200/3204A23L33/135A61P1/02A61P19/00A61P43/00C12R2001/225C12N1/205A23V2400/175A23V2400/165A23V2400/237A23K50/10A23K50/30A23K50/40A23K50/50A23K50/70A23K50/75A23K50/80A23L7/10A61K8/0216A61K8/042A61K8/60
Inventor KAESLER, BRUNOKNOLL, ROLFBOETTNER, MEWESBUDDE, ECKHARDLANG, CHRISTINERYSER, MARTINVEEN, MARKUS
Owner BASF AG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap